COA Series: What are Clinician-Reported Outcomes (ClinROs)? This webinar featured John H. Powers III, MD, FACP, FIDSA [C], Professor of Clinical Medicine, George Washington University School of Medicine. Clinician-reported outcome (ClinRO) […]
Patient Engagement
Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration
Dr. Eleanor Perfetto, NHC Executive Vice President, Strategic Initiatives, co-authored a paper titled, “Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration,” which was published […]
CMS RFI: Reducing Administrative Burden to Put Patients over Paperwork
By Madison Mason, Policy Associate The Centers for Medicare and Medicaid Services (CMS) released a request for information (RFI), seeking stakeholder opinion regarding their Patients over Paperwork initiative. Patients over […]
The Sentinel System— An Overview of FDA’s Tools for Assessing Medical Product Safety and Gathering Real-World Evidence
The Sentinel System— An Overview of FDA’s Tools for Assessing Medical Product Safety and Gathering Real-World Evidence This webinar provided an overview of Sentinel’s growing capabilities and value in regulatory […]
NHC CEO Marc Boutin on Patients as Partners in Innovation, Education, and More at eyeforpharma
By Christina Howerton, Manager, Communications and New Media In April, National Health Council Chief Executive Marc Boutin, JD, participated in a fireside chat with Percival Barretto-Ko, President of Astellas Pharma, […]
Centers for Medicare & Medicaid Services’ (CMS’) Request for Information: Reducing Administrative Burden to Put Patients over Paperwork
The National Health Council (NHC) appreciates the opportunity to respond to the Centers for Medicare & Medicaid Services’ (CMS’) Request for Information entitled “Reducing Administrative Burden to Put Patients over […]
Food and Drug Administration’s (FDA’s) Draft Guidance on Enhancing the Diversity of Clinical Trial Populations
The National Health Council (NHC) appreciates the opportunity to provide comments on the Food and Drug Administration’s (FDA’s) draft guidance on Enhancing the Diversity of Clinical Trial Populations. While industry […]
Core Outcome Sets – What are They?
By Aimee Lee Russell, Associate, Programs On Monday, July 15, Donna Messner, PhD, CEO and President of the Center for Medical Technology Policy (CMTP) introduced core outcome sets and described why […]
NHC 2019 Science of Patient Engagement Symposium Highlights Using Data Science, Technology, and Patient Engagement to Personalize Health Care
By Silke Schoch, Senior Associate, Programs On October 28 and 29, the National Health Council (NHC) held its third annual Science of Patient Engagement Symposium in Washington, DC. The theme […]
What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism
The following is an excerpt from a study co-authored by Eleanor M. Perfetto, PhD, MS, National Health Council’s Executive Vice President, Strategic Initiatives, published on July 26, 2019. Read the […]